Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT versus sertraline in depression with poorly controlled insulin-treated diabetes
2005-004525-26Phase 4Completed
- Sponsor
- Ruhr University Bochum
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sertraline in major depressive disorder (MDD) (2 arms), sponsored by Ruhr University Bochum. Primary endpoint: Clinically important improvement in glycaemic control. Started Feb 2006; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-004525-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004525-26.